DIRS.INFO The most relevant business & tech news

☆ Opinion | Speech and Antisemitism on Campus
▼ + stars: | 2023-11-13 | by ( ) www.nytimes.com time to read: +5 min

And he rightly suggests necessary limits on a culture of free speech, including prohibitions on harassment and targeting based on ethnic or religious identity. We can build our bastions of free speech on the foundational layers of moral clarity and intellectual integrity. To the Editor:Re “What Is Happening on College Campuses Is Not Free Speech,” by Gabriel Diamond, Talia Dror and Jillian Lederman (Opinion guest essay, Nov. 11):Protecting free speech on campus requires bravery and intellectual honesty, not partisan definitions. As Jewish students, we share in the real fear surrounding the rise of violent threats against our communities. Upholding free speech requires empathy and consistency, and we must understand that intimidation and fear on campuses are real, and they are not felt only or even primarily by Jewish students.

Persons: Jesse Wegman, Wegman, Rabbi, Ari Berman, Gabriel Diamond, Talia Dror, Jillian Lederman, ”, Eliana Blumberg Rita Feder Michael Farrell, Rosen Providence, Lawrence D, Platt Los Angeles, Joshua Rosenbaum Brooklyn, Joe Manchin, … Organizations: Hamas, Yeshiva University, Holocaust, Israel, Jewish, Brown University, College, University, Touro University Locations: Israel, Chicago, R.I, American, Europe

☆ Corporate America weighs business impact of new weight-loss drugs
▼ + stars: | 2023-11-08 | by ( ) www.reuters.com time to read: +4 min

Walmart (WMT.N) expects revenues from its health and wellness products to increase in the second half of the year, mainly due to the popularity of weight-loss drugs. PepsiCo (PEP.O) Chief Financial Officer Hugh Johnston has said the company is "not seeing any impact" yet from the popularity of weight-loss drugs. Coca-Cola (KO.N) CEO James Quincey said the company was monitoring what impact, if any weight-loss drugs will have. Abbott CEO Robert Ford has said diabetes patients could end up using glucose monitors with the weight-loss drugs in the long term. DRUG DISTRIBUTORSCencora (COR.N), formerly called AmerisourceBergen, Cardinal Health (CAH.N) and McKesson (MCK.N) have flagged potential boost to revenues this year owing to the growing demand for weight-loss drugs.

Persons: Victoria Klesty, Eli Lilly's, Eli Lilly's Zepbound, Hugh Johnston, James Quincey, Michele Buck, Dr Pepper, Robert Gamgort, Johnson, Joseph Wolk, Robert Ford, Michael Farrell, Bhanvi Satija, Ananya Mariam Rajesh, Mrigank Dhaniwala, Arun Koyyur Organizations: REUTERS, U.S . Food, Drug Administration, Walmart, PepsiCo, J, Abbott Laboratories, Insulet Corp, Boston Scientific, Cardinal Health, Thomson Locations: Oslo, Norway, Victoria, U.S, GLP, Bengaluru

Such forecasts have prompted a sell-off in a wide range of companies from makers of bariatric surgery devices to companies whose products address the health issues created by excess weight, from diabetes to sleep apnea. "The market is in a shoot-first, ask-questions-later mood when it comes to weight-loss drugs," said Nicholas Anderson, manager of the Thornburg International Growth Fund, which holds shares of Novo Nordisk. By contrast, the iShares U.S. Medical Devices exchange-traded fund has lost more than 22% in the last three months. Injectable weight-loss drugs, known as GLP-1 receptor agonists, are considered highly effective but are also expensive, costing more than $1,300 per month. "Overall, we'll see an increased interest in bariatric surgery, but that will get delayed in the short term."

Persons: Doctor Thomas Horbach, Wegovy, Nicholas Anderson, Eli Lilly, Kenneth Stein, Margaret Kaczor Andrew, William Blair, Michael Farrell, Jeff Jonas, Johnson, Myriam Curet, Ann Hynes, Hynes, David Gaffen, Manas, Michael Erman, Caroline Humer, Sonali Paul Organizations: Novo Nordisk, Healthcare, Growth Fund, Medical Devices, Boston, Gabelli Funds, Johnson, Reuters, Mizuho Securities, Manas Mishra, Thomson Locations: Germany, Munich, Danish, U.S, Boston, GLP, New York, Bengaluru

New anti-obesity drugs have the potential to transform public health, while obliterating demand for products and services from the medical, food and fitness industries. Drugs developed by Novo Nordisk (NOVOb.CO) and Eli Lilly (LLY.N) appear to be the first truly effective diet treatments. In one clinical trial, patients taking Eli Lilly’s soon-to-be-launched weight-loss drug lost about 50 pounds (23 kg). Only about a third of those who started taking the drugs for obesity were still doing so a year later, according to one analysis. Yet even as Novo, Lilly and others see their addressable markets expand, some companies will see theirs shrink.

Persons: Lilly, George Frey, Eli Lilly, Eli Lilly’s, Novo, Wegovy, Kraft Heinz, Burger, LSEG, Michael Farrell, Zimmer Biomet, Smith, Peter Thal Larsen, Sharon Lam, Oliver Taslic Organizations: Novo Nordisk, Pharmacy, REUTERS, Reuters, TAM, Drugs, Alpha, Reuters Graphics Reuters, Cadbury, Mondelez, Fortune Business, Burger King, KFC, Yum Brands, Centers for Disease Control, Milken Institute, BMJ, Novo, Inspire Medical Systems, Novo Nordisk’s, WW International, Fashion, Thomson Locations: Provo , Utah, U.S, New, United States, Lilly, England

☆ How much is a good night's sleep worth? A lot to these stocks
▼ + stars: | 2023-09-04 | by ( Michelle Fox | ) www.cnbc.com time to read: +13 min

In fact, some 63% of U.S. adults sleep less than the recommended seven to nine hours a night, according to the National Sleep Foundation's Sleep Health Index. There are a myriad of products in the sleep arena — from mattresses and sleep supplements to sleep apnea devices and tech wearables that track sleep. Treating sleep conditions Health conditions can also impact the ability to get a good night's rest, like insomnia and sleep apnea. Obstructive sleep apnea causes breathing to be interrupted during sleep. About half of those surveyed in its obstructive sleep apnea patient survey in July said they had never heard of Inspire.

Persons: Anna Pione, they'll, Seth Basham, Basham, Tempur Sealy, " Basham, It's, Stefano Natella, Natella, it's, Ollie, Seamus Fernandez, Philip's, Philips, Eli Lilly, Eli Lilly's, Guggenheim's Fernandez, Michael Farrell, we've, Fernandez, Novo, wearables, Gene Munster, Jason Ware, Ware, Pione, Michael Bloom Organizations: McKinsey, International Sleep Products, Sealy International, Mattress, Sealy, Centers for Disease Control, Guggenheim, CDC, Unilever, American, of, Care, American Medical Association, Bank of America Securities, Medical Systems, Bank of America, Inspire, Novo Nordisk, Garmin, Apple, Deepwater Asset Management, Apple Watch, Albion Financial, Munster Locations: U.S, dreamland, Mizuho, Novo

By comparison, less than 5% of companies mentioned AI in analyst calls held during the first quarter of 2016. Big Tech mentions jump AI has been a growing theme in Big Tech as companies try to capitalize on the wave following 2022's selloff. In calls from Big Tech companies alone, AI was mentioned 265 times. Executives at real estate company UDR said its AI chat has a 10% higher closing rate than normal call centers. Interpublic Group of Companies CEO Philippe Krakowsky noted the advertising company brought on a chief AI officer two years ago.

☆ Resmed is 'thinking broadly' in its supply chain globally, says CEO
▼ + stars: | 2022-11-17 | by ( ) www.cnbc.com time to read: 1 min

Share Share Article via Facebook Share Article via Twitter Share Article via LinkedIn Share Article via EmailResmed is 'thinking broadly' in its supply chain globally, says CEOMichael Farrell of Resmed discusses the company's growth strategy after opening its largest advanced manufacturing plant in Singapore.

☆ Intensitatea discursului de ură crește în campaniile electorale, masă rotundă
▼ + stars: | 2021-06-11 | by ( ) www.ipn.md time to read: +6 min

Intensitatea discursului de ură crește în campaniile electorale, masă rotundăIntensitatea discursului de ură și discriminare crește în campaniile electorale, când este folosit ca metodă de luptă între concurenții electorali. Combaterea discursului de ură, instigării la ură trebuie să fie o condiție pentru toți actorii electorali, organele electorale, pentru CEC, Consiliul Audiovizualului, Consiliul pentru prevenirea discriminării, Avocatul Poporului. Discursul e ură este legat, de asemenea, de anumite influențe geopolitice, cum sunt percepute anumite instituții, țările vecine etc. Consiliul crede că ar trebui să fie responsabil, ca instituție de profil, pentru examinare, avizarea, constatarea discursului de ură. Alt fapt ține de colectarea datelor pe crimele motivate de ură și aici trebuie să se acționeze împreună cu MAIE.

Persons: Vladimir, Poporului, El, Ala Ursu, Michael Farrell, Mara Georgescu, Ian Feldman Organizations: Europei, CEC, Consiliul Audiovizualului, Consiliului Audiovizualului, Audiovizualului, Europeană Locations: Republica Moldova, Chișinău, Republicii Moldova, transnistreană, Antoci, MAIE

Search resuls for: "Michael Farrell"

8 mentions found